Pharmanutra S.p.A. (PHN.MI)

EUR 54.8

(1.86%)

Total Debt Summary of Pharmanutra S.p.A.

Pharmanutra S.p.A.'s latest annual total debt in 2023 was 28.01 Million EUR , up 58.04% from previous year.
Pharmanutra S.p.A.'s latest quarterly total debt in 2024 Q1 was 28.39 Million EUR , up 1.35% from previous quarter.
Pharmanutra S.p.A. reported annual total debt of 17.72 Million EUR in 2022, up 179.33% from previous year.
Pharmanutra S.p.A. reported annual total debt of 6.34 Million EUR in 2021, up 282.52% from previous year.
Pharmanutra S.p.A. reported quarterly total debt of 28.39 Million EUR for 2024 Q1, up 1.35% from previous quarter.
Pharmanutra S.p.A. reported quarterly total debt of 25.7 Million EUR for 2023 Q2, up 41.55% from previous quarter.

Annual Total Debt Chart of Pharmanutra S.p.A. (2023 - 2015)

Historical Annual Total Debt of Pharmanutra S.p.A. (2023 - 2015)

Year	Total Debt	Total Debt Growth
2023	28.01 Million EUR	58.04%
2022	17.72 Million EUR	179.33%
2021	6.34 Million EUR	282.52%
2020	1.65 Million EUR	-74.09%
2019	6.4 Million EUR	19.84%
2018	5.34 Million EUR	-4.84%
2017	5.61 Million EUR	15.84%
2016	4.84 Million EUR	-14.21%
2015	5.65 Million EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	27.05 Million EUR	-4.73%
2024 Q1	28.39 Million EUR	1.35%
2023 Q2	25.7 Million EUR	41.55%
2023 FY	28.01 Million EUR	58.04%
2023 Q3	24.9 Million EUR	-3.14%
2023 Q4	28.01 Million EUR	12.51%
2023 Q1	18.16 Million EUR	2.45%
2022 Q2	11.76 Million EUR	97.63%
2022 Q4	17.72 Million EUR	-2.47%
2022 FY	17.72 Million EUR	179.33%
2022 Q1	5.95 Million EUR	-6.21%
2022 Q3	18.17 Million EUR	54.5%
2021 Q2	1.69 Million EUR	8.54%
2021 Q1	1.55 Million EUR	-6.15%
2021 FY	6.34 Million EUR	282.52%
2021 Q4	6.34 Million EUR	-3.38%
2021 Q3	6.56 Million EUR	288.64%
2020 Q1	- EUR	-100.0%
2020 FY	1.65 Million EUR	-74.09%
2020 Q2	3.47 Million EUR	0.0%
2020 Q4	1.65 Million EUR	-32.64%
2020 Q3	2.46 Million EUR	-29.12%
2019 Q2	5.07 Million EUR	5.39%
2019 FY	6.4 Million EUR	19.84%
2019 Q4	6.4 Million EUR	0.0%
2019 Q1	4.81 Million EUR	-9.84%
2018 Q3	5.34 Million EUR	10.1%
2018 Q4	5.34 Million EUR	0.02%
2018 FY	5.34 Million EUR	-4.84%
2018 Q1	4.85 Million EUR	-13.59%
2018 Q2	4.85 Million EUR	0.0%
2017 Q2	5.99 Million EUR	-0.01%
2017 Q1	5.99 Million EUR	23.77%
2017 Q4	5.61 Million EUR	0.01%
2017 Q3	5.61 Million EUR	-6.41%
2017 FY	5.61 Million EUR	15.84%
2016 FY	4.84 Million EUR	-14.21%
2016 Q3	4.84 Million EUR	0.0%
2016 Q1	- EUR	0.0%
2016 Q4	4.84 Million EUR	-0.0%
2015 FY	5.65 Million EUR	0.0%

Peer Total Debt Comparison of Pharmanutra S.p.A.

Name	Total Debt	Total Debt Difference